UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

Clinical cancer research, 2020-02, Vol.26 (3), p.598-607

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

Clinical cancer research, 2011-10, Vol.17 (20), p.6467-6481

2011

Link zum Volltext

Verfügbarkeit prüfen

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Immunity (Cambridge, Mass.), 2018-12, Vol.49 (6), p.1148-1161.e7

2018

Link zum Volltext

Verfügbarkeit prüfen

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

Molecular therapy. Oncolytics, 2022-06, Vol.25, p.174-188

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Clinical cancer research, 2020-06, Vol.26 (12), p.2827-2837

2020

Link zum Volltext

Verfügbarkeit prüfen

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro

Molecular therapy. Nucleic acids, 2017-03, Vol.6, p.221-232

2017

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Cancer immunology research, 2020-02, Vol.8 (2), p.246-254

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Biomarkers for Melanoma Immunotherapy

Current oncology reports, 2020-03, Vol.22 (3), p.25-25, Article 25

2020

Link zum Volltext

Verfügbarkeit prüfen

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Immunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1749-1749

2022

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity

Molecular cancer research, 2022-06, Vol.20 (6), p.983-995

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence

The Journal of immunology (1950), 2012-07, Vol.189 (2), p.767-776

2012

Link zum Volltext

Verfügbarkeit prüfen

Multiple vaccinations: friend or foe

The cancer journal (Sudbury, Mass.), 2011-09, Vol.17 (5), p.379

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus IL12 plasmid DNA

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.65-65.20

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3195: Intratumoral electroporation of plasmid IL-12 and CXCL9 with membrane-bound anti-CD3 elicits robust anti-tumor immunity

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3195-3195

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT022: Intratumoral plasmid IL-12 and electroporation in pre-treated inoperable locally advanced or recurrent triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT022-CT022

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-14-06: Durable responses with intratumoral electroporation of plasmid interleukin-12 plus pembrolizumab in patients with advanced triple-negative breast cancer: Cohort 1 update from KEYNOTE-890

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-14-06

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity

Cancer immunology research, 2022-01, Vol.10 (1_Supplement), p.P006-P006

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-396: Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.LB-396-LB-396

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-390: Intratumoral electroporation of plasmid-encoded IL-12 and membrane-bound anti-CD3 increases tumor immunogenicity and augments the function of T cell subsets

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.LB-390-LB-390

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses: T cell responses induced by plasmid IL-12 electroporation

Cancer immunology research, 2019-12, Vol.8 (2), p.246-254

2019

Link zum Volltext

Verfügbarkeit prüfen

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016

Journal for immunotherapy of cancer, 2016-12, Vol.4 (S2), Article 91

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Oncology
(7)
Cd8-Positive T-Lymphocytes - Immunology
(5)
Humans
(5)
Animals
(4)
Female
(4)
Immunology
(4)
Immune Checkpoint
(3)
Immunotherapy
(3)
Immunotherapy - Methods
(3)
Lymphocytes T
(3)
Melanoma - Therapy
(3)
Mice
(3)
Mice, Inbred C57bl
(3)
Plasmids - Administration & Dosage
(3)
T-Lymphocytes - Immunology
(3)
Treatment Outcome
(3)
Aged
(2)
Aged, 80 And Over
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro

Intratumoral Plasmid IL12 Expands CD8 + T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Prognostic Biomarkers for Melanoma Immunotherapy

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence

Multiple vaccinations: friend or foe

Evaluation of the long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus IL12 plasmid DNA

Abstract 3195: Intratumoral electroporation of plasmid IL-12 and CXCL9 with membrane-bound anti-CD3 elicits robust anti-tumor immunity

Abstract CT022: Intratumoral plasmid IL-12 and electroporation in pre-treated inoperable locally advanced or recurrent triple-negative breast cancer (TNBC)

Abstract P2-14-06: Durable responses with intratumoral electroporation of plasmid interleukin-12 plus pembrolizumab in patients with advanced triple-negative breast cancer: Cohort 1 update from KEYNOTE-890

Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity

Abstract LB-396: Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity

Abstract LB-390: Intratumoral electroporation of plasmid-encoded IL-12 and membrane-bound anti-CD3 increases tumor immunogenicity and augments the function of T cell subsets

Intratumoral plasmid IL-12 expands CD8+ T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy

Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses: T cell responses induced by plasmid IL-12 electroporation

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016

Suchergebnisse filtern